ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
LJSM
|
1.4K |
544K |
0 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
1.4K
|
544K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive final DEP irinotecan Phase 2 clinical trial results
|
|
LJSM
|
42 |
9.7K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
42
|
9.7K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Scenesse expanding to 4+ implants annually in the EU?
|
|
LJSM
|
7 |
1.6K |
2 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
7
|
1.6K
|
2
|
|
ASX - By Stock
|
NWH |
Re:
Ann: Change of Director's Interest Notice
|
|
LJSM
|
13 |
2.7K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
13
|
2.7K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL and Valentech enter Latin American partnership
|
|
LJSM
|
6 |
2.0K |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
6
|
2.0K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Investor Webinar Notification - SPL Business Update
|
|
LJSM
|
43 |
8.8K |
5 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
43
|
8.8K
|
5
|
|
ASX - By Stock
|
NWH |
Re:
Ann: Change of Director's Interest Notice
|
|
LJSM
|
13 |
2.7K |
4 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
13
|
2.7K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
LJSM
|
1.4K |
544K |
7 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
1.4K
|
544K
|
7
|
|
ASX - By Stock
|
AMN |
Re:
Ann: West Arunta Exploration Update
|
|
LJSM
|
49 |
16K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
49
|
16K
|
1
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
LJSM
|
1.4K |
544K |
2 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.4K
|
544K
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Syd Capital Markets Briefing Presentation
|
|
LJSM
|
38 |
14K |
4 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
38
|
14K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
LJSM
|
1.4K |
544K |
4 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
1.4K
|
544K
|
4
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
LJSM
|
117 |
45K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
117
|
45K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
LJSM
|
1.6K |
481K |
5 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
1.6K
|
481K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
LJSM
|
495 |
166K |
12 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
495
|
166K
|
12
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
LJSM
|
53 |
10K |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
53
|
10K
|
0
|
|
ASX - By Stock
|
SYR |
Re:
Ann: March 2024 Quarterly Activities Presentation
|
|
LJSM
|
19 |
9.2K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
19
|
9.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
LJSM
|
53 |
10K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
53
|
10K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
LJSM
|
31 |
14K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
31
|
14K
|
7
|
|
ASX - By Stock
|
AMN |
Re:
Ann: Quarterly Activities Report
|
|
LJSM
|
7 |
2.0K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Ceasing to be a substantial holder
|
|
LJSM
|
2 |
1.0K |
7 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
2
|
1.0K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
LJSM
|
1.6K |
481K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
1.6K
|
481K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
LJSM
|
1.6K |
481K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
1.6K
|
481K
|
2
|
|
ASX - By Stock
|
NWH |
Re:
Ann: Gascoyne Update
|
|
LJSM
|
199 |
71K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
199
|
71K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
LJSM
|
750 |
290K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
750
|
290K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
LJSM
|
46 |
16K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
16K
|
12
|
|
ASX - By Stock
|
NWH |
Re:
Ann: Gascoyne Update
|
|
LJSM
|
199 |
71K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
199
|
71K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
LJSM
|
4.2K |
3.7M |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Update - Notification of buy-back - CUV
|
|
LJSM
|
9 |
2.6K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
9
|
2.6K
|
4
|
|
ASX - By Stock
|
NWH |
Re:
News: NWH NRW Holdings Declares Interim Dividend 6.5 AU Cents Per Share
|
|
LJSM
|
5 |
1.8K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
5
|
1.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
LJSM
|
495 |
166K |
9 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
495
|
166K
|
9
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Update - Notification of buy-back - CUV
|
|
LJSM
|
8 |
2.1K |
7 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
8
|
2.1K
|
7
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Syrah natural graphite sales and market update
|
|
LJSM
|
24 |
13K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
24
|
13K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
LJSM
|
148 |
29K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
29K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
LJSM
|
31 |
9.0K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
31
|
9.0K
|
7
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Syrah natural graphite sales and market update
|
|
LJSM
|
24 |
13K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
24
|
13K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Update - Notification of buy-back - CUV
|
|
LJSM
|
24 |
7.5K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
24
|
7.5K
|
3
|
|
ASX - By Stock
|
AMN |
Re:
Ann: Launch of Share Purchase Plan
|
|
LJSM
|
21 |
9.4K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
21
|
9.4K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Interim decision to amend the Poison Standard for astodrimer sodium
|
|
LJSM
|
32 |
7.7K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
32
|
7.7K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
LJSM
|
103 |
40K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
103
|
40K
|
9
|
|
ASX - By Stock
|
CUV |
Re:
Food for Thought
|
|
LJSM
|
31 |
9.7K |
4 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
31
|
9.7K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Letter from Cheryl..
|
|
LJSM
|
72 |
17K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
72
|
17K
|
1
|
|
ASX - By Stock
|
AMN |
Re:
Ann: West Arunta Exploration Update
|
|
LJSM
|
49 |
16K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
49
|
16K
|
4
|
|
ASX - By Stock
|
SYR |
Re:
Ann: 31 December 2023 Annual Report
|
|
LJSM
|
38 |
13K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
38
|
13K
|
5
|
|
ASX - By Stock
|
NWH |
Re:
2024 General news etc
|
|
LJSM
|
53 |
17K |
2 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
53
|
17K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Part 1 Remplir US Market Authorisation Successfully Complete
|
|
LJSM
|
35 |
10K |
8 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
35
|
10K
|
8
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
LJSM
|
103 |
40K |
7 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
103
|
40K
|
7
|
|
ASX - By Stock
|
SYR |
Re:
SPP - Will you be participating
|
|
LJSM
|
33 |
10K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Newsletter II - March 2024
|
|
LJSM
|
20 |
7.1K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
20
|
7.1K
|
2
|
|
ASX - By Stock
|
AXE |
Re:
What is happening
|
|
LJSM
|
3.4K |
1.4M |
7 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
3.4K
|
1.4M
|
7
|
|